Cordyceps Sinensis And Militaris Extract Market Analysis & Forecast: 2026-2033
The global cordyceps sinensis and militaris extract market was valued at USD 1,628.6 Mn in 2026 and is forecast to reach a value of USD 3,344.4 Mn by 2033 at a CAGR of 10.9% between 2026 and 2033.
Cordyceps sinensis and cordyceps militaris are a parasitic fungus species and dead caterpillars that have numerous possible health benefits. It has been used as a treatment for about 21 illnesses, including low immunity, high blood pressure, etc., in traditional Chinese medicine and Tibetan medicine. The living larva is slowly degraded and mummified in the soil as a result of cordyceps spores growing inside the caterpillar's body and infecting it. Eventually, a cordyceps stem develops from the caterpillar's head.
|
Current Event |
Description and its Impact |
|
China's Environmental and Regulatory Policies on Traditional Medicine |
|
|
Biotechnology Advancements in Cultivation and Extraction |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
In terms of formulation, the extract powder sub-segment, under the powder segment is expected to hold the 47.2% share of the market in 2026, because they are flexible, easy to mix into capsules, teas, and functional foods, and they keep high concentration of bioactive compounds. Manufacturers and consumers prefer them for their longer shelf life and are easier to use. This is especially true in the nutraceuticals market, where they will have almost half of the market share in 2026.
In terms of application, the dietary supplements segment is expected to lead the market with 57.8% share in 2026, due to rising consumer interest in natural adaptogens to boost their immune system, energy, and stress levels. Cordyceps extracts are widely marketed as they can improve health and performance. Supplements are largest application category by 2026 because they are easier to regulate than pharmaceuticals.
For instance, in August 2025, The MushCanyon announcement addresses its 2025 release of functional mushroom gummies with clean-label formulas that help with focus, calmness, immune balance, and energy. Cordyceps is one of the mushroom extracts, positioning it as a dietary supplement ingredient. This shows that growing consumer demand wellness products that contain natural adaptogens that are easy to use.
In terms of strain type, the cordyceps militaris segment is projected to account for 62.4% share of the market in 2026, as it can be grown in controlled environments, it is affordable, and consistent cultivation in controlled environments. Militaris, on the other hand, gives reliable amounts of cordycepin and polysaccharides. Sinensis is rare and expensive. It is the most popular strain for commercial extraction because it is easy to get. In 2026, it will make up almost two-thirds of the market.
To learn more about this report, Download Free Sample
Asia Pacific is expected to lead the cordyceps sinensis and militaris extract market with 40% share in 2026, due to Cordyceps has been used in Chinese and Ayurvedic medicine for a long time. China, India, Japan, and South Korea are major contributors as they have well-known brands and established supply chains. The area benefits from cultural credibility, a lot of farmlands, and government support for herbal medicine, which will make it the primary provider of income in 2026.
For instance, in August 2025, The HEC Group–JungKwanJang alliance is based on HEC's knowledge of Cordyceps Sinensis ecological breeding and JungKwanJang's leadership in red ginseng. The partnership, which was announced in Singapore, aims to make "Red Ginseng + Cordyceps" products that are co-branded and sold in health markets around the world and in Asia-Pacific. This will boost innovation and premium nutraceutical offerings around the world.
North America is expected to exhibit the fastest growth. Rising health consciousness, demand for natural supplements, and the nutraceutical and functional food industries are growing. The U.S. and Canada are seeing rapid growth in dietary supplements and pharmaceutical applications, supported by more people are interested in plant-based remedies and more research is being performed on them.
For instance, in October 2025, the launch of M2 Ingredients showcased new whole mushroom extracts, such as CordyExtract™ (Cordyceps extract), LionXtract™ (Lion's Mane), ReiExtract™ (Reishi), and Myco-Six™ (a blend of six mushrooms). The company is based in California and focuses on organically grown, U.S.-sourced mushrooms for dietary supplements, functional foods, and drinks. This helps the wellness and nutraceutical market become more innovative.
In China, the Cordyceps Sinensis and Militaris Extract Market is highly popular in 2026 because it has a long history in Traditional Chinese Medicine, where Cordyceps is used to improve immunity, respiratory health, and energy. The growth of both domestic and international sales of herbal remedies is driven by strong cultural acceptance, large-scale farming, and government support.
For instance, in March 2025, according to a study from China, cordycepin, which comes from the fungus Cordyceps militaris, helps mice run longer and think more clearly when they are tired. The compound improved endurance and cognition, which makes it even more relevant to Cordyceps dietary supplements that boost energy, stamina, and mental clarity in the global nutraceutical and functional health markets.
In 2026, the Cordyceps Sinensis and Militaris Extract Market in the United States due to rising consumer awareness of adaptogenic and the immune-boosting and adaptogenic benefits. There is a strong preference for natural remedies, reflected by dietary supplements, functional foods, and pharmaceutical applications are growing so quickly.
For instance, in November 2025, the launch of LifeBridge's IQ Air lung health supplement in the United States, specifically in Fort Lauderdale, Florida, where the company made the announcement. The supplement combines Cordyceps mushroom extract, vitamin D3, and antioxidants to help keep your lungs healthy during the cold and flu season in the U.S.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1,628.6 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 10.9% | 2033 Value Projection: | USD 3,344.4 Mn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Lubrizol Corporation, Naturalin bio-resources co. Ltd., NU SKIN ENTERPRISES INC., Quyuan sunnycare Inc., Shanghai Kangzhou Fungi Extract Co. Ltd., Xi'an Saina Biological Technology Co. Ltd. (Herbsino), Dalong Biotechnology Co. Ltd., Health Choice Limited, Nutra Green Biotechnology Co. Ltd, Sunrise Nutrachem Group Ltd., Ojas Farms, Golden Vital Agro Herbal Private Limited, MycoForest |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
The Cordyceps Sinensis and Militaris Extract Market growth is quick because a growing number of individuals around the world are taking dietary supplements. Consumers are using increasingly turning to natural remedies to boost their energy, stamina, and immunity. This is especially true since the pandemic made people more aware of their health. Cordyceps extracts are offered as adaptogens that boost overall health, which is why they are popular with health-conscious people and athletes. The growing preference for herbal supplements over synthetic is helping the market grow and making it more global.
The Cordyceps Sinensis and Militaris Extract market demand is also rising owing to its growing use in medicine and healthcare. Researchers are seeking into cordyceps' anti-inflammatory, antioxidant, and possible anti-cancer properties, which makes them interesting for functional medicine and drug development. As research shows that these bioactive compounds really work, pharmaceutical companies are using greater quantities of Cordyceps extracts in their products. This trend not only makes them more credible, but it also opens up new uses for them outside of traditional medicine, which is driving demand in clinical and therapeutic fields around the world.
The Cordyceps Sinensis and Militaris Extract Market forecast shows that there will be significant opportunities in the functional food and beverage market. Manufacturers are placing Cordyceps extracts into teas, coffees, energy drinks, and protein bars instead of just capsules and powders. This diversification not only reaches more customers, but it also fits with the trend of people living healthier lives. Companies can strengthen their brand positioning, reach new demographics, and drive long-term market growth among health-conscious people around the world by adding Cordyceps to everyday products.
The market for Cordyceps sinensis and Cordyceps militaris extracts is growing in the nutraceutical and functional ingredients space, because there is always a demand for bioactive compounds that help with energy, immune system, and adaptogenic benefits. According to industry data, C. militaris has surpassed C. sinensis in commercial extraction volumes due to it is easier to grow and has more cordycepin, which is becoming more common in scientific literature for its pharmacological activity.
Estimates of the scale of production show that most of the world's extract supply comes from cultivated C. militaris biomass, driven by controlled fermentation and substrate technologies allow for year-round output. Traditional wild-harvest C. sinensis, mostly from certain high-altitude areas, is still a high-quality ingredient, but it makes up a smaller part of the overall extract market because of its limited availability and higher costs. Analytical profiles consistently demonstrate that C. militaris extracts produce elevated cordycepin concentrations, whereas C. sinensis is esteemed for its diverse array of nucleosides and polysaccharides.
Quality and standardization are key to market legitimacy. Third-party tests for mycotoxins, heavy metals, and bioactive quantification are becoming standard in the industry, and regulatory frameworks are requiring clear labeling of extract ratios and constituent profiles more and more. In general, the market is known for strong product innovation, differentiation based on bioactive potency, and more uses in health-conscious consumer groups.
Share
Share
About Author
Ghanshyam Shrivastava - With over 20 years of experience in the management consulting and research, Ghanshyam Shrivastava serves as a Principal Consultant, bringing extensive expertise in biologics and biosimilars. His primary expertise lies in areas such as market entry and expansion strategy, competitive intelligence, and strategic transformation across diversified portfolio of various drugs used for different therapeutic category and APIs. He excels at identifying key challenges faced by clients and providing robust solutions to enhance their strategic decision-making capabilities. His comprehensive understanding of the market ensures valuable contributions to research reports and business decisions.
Ghanshyam is a sought-after speaker at industry conferences and contributes to various publications on pharma industry.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
Schedule a meeting with report Author
